All Indications Point to Billion Dollar CBD Markets Should Continue to Skyrocket

Palm Beach, FL – October 8, 2019 – Industry reports all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. As consumers accept… and even demand more CBD products, the future is projected to continue to rise in years to come. Statista has reported that it expects that U.S. consumer […]

These are the Biggest Catalysts for CBD in 2020

Palm Beach, FL – October 8, 2019 – Investors would be hard-pressed to find an industry expected to nearly double in value over the next four years.  The Brightfield Group says CBD could grow to into a $23.7 billion a year industry in the U.S. by 2023 – a CAGR of 100%.  Better, consumers are […]

Why the U.S. Should Be the Epicenter of Artificial Intelligence (AI) Industry

Palm Beach, FL –October 8, 2019 – Many observers equate the rise/appearance of artificial intelligence (AI) with a prophetical statement made in 1969… to paraphrase, AI is “a giant leap for Mankind”! A Grandview report proffered that Artificial Intelligence: “… (should be) considered to be the next stupendous technological development, alike past developments such as […]

Integrated Cannabis’ Ganja Gold Announces California Launch of first CBD Infused Pre-RollIntegrated Cannabis’ Ganja Gold Announces California Launch of first CBD Infused Pre-Roll

Vancouver, BC,  – October 8, 2019 – Integrated Cannabis Company, Inc. (CSE: ICAN) (OTCQB: ICNAF) (“Integrated Cannabis” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that its wholly-owned subsidiary, Ganja Gold, has launched the first cannabidiol (CBD) infused pre-roll in California.  The novel pre-roll is designed for those […]

Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Palm Beach, FL – October 8, 2019 – Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases – trends that expand healthcare spending. While the global market is projected to continue its rapid growth, it is the U.S. that has the largest share of […]

Soliton To Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Results to be Presented at American Society for Dermatologic Surgery Annual Meeting   Houston, TX – October 8, 2019 – Soliton, Inc., (NASDAQ: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today […]